Yonhap Infomax NewsCelltrion announced at the JPMorgan Healthcare Conference that it will expand its new drug pipeline and U.S. manufacturing, aiming to quadruple its biosimilar portfolio and strengthen its global market position.
#YonhapInfomax #Celltrion #NewDrugDevelopment #BiosimilarPortfolio #JPMorganHealthcareConference #BranchburgFacility #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=99729
#YonhapInfomax #Celltrion #NewDrugDevelopment #BiosimilarPortfolio #JPMorganHealthcareConference #BranchburgFacility #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=99729
Seo Jin-seok, CEO of Celltrion, Announces Major Expansion of New Drug Development at JPMorgan Healthcare Conference
Celltrion announced at the JPMorgan Healthcare Conference that it will expand its new drug pipeline and U.S. manufacturing, aiming to quadruple its biosimilar portfolio and strengthen its global market position.